Interim report
Page 1
Disclaimer : This document is an English translation of the original document in Japanese and has been prepared solely for reference purposes . In the event of any discrepancy between this English translation and the original in Japanese , the original shall prevail in all respects . Consolidated Financial Results for the Three Months Ended June 30 , 2026 ( Under Japanese GAAP ) Accounting Standards Fo FASF MEMBERSHIP August 7 , 2026 Name of listed company : Code : SHIP HEALTHCARE HOLDINGS , INC . Shares listed on : Tokyo Stock Exchange 3360 URL https://www.shiphd.co.jp/en/ Representative : ( Title ) President Contact : ( Title ) Executive Vice President ( Name ) Futoshi Ohashi ( Name ) Hiroshi Yokoyama Tel .: + 81-6-6369-0130 Scheduled start date for dividend payments : - Supplementary briefing materials on results : Yes Briefing on quarterly results : None ( All figures are rounded down to the nearest million yen . ) 1. Consolidated financial results for the three months ended June 30 , 2026 ( April 1 , 2026 - June 30 , 2026 ) ( 1 ) Consolidated operating results ( cumulative total ) Three months ended June 30 , 2026 June 30 , 2025 ( Percentages represent year - on - year changes . ) Profit attributable to Net sales ( Million yen ) 176,361 163,310 % Operating profit ( Million yen ) Ordinary profit % ( Million yen ) 8.0 2,784 ( 5.7 ) 3,383 % 9.2 owners of parent ( Million yen ) % 2,090 2.9 5.2 2,953 ( 15.8 ) 3,099 ( 31.0 ) 2,030 ( 34.1 ) Note : Comprehensive income : Three months ended June 30 , 2026 : ¥ 2,026 million ( ( 14.4 ) % ) Three months ended June 30 , 2025 : ¥ 2,367 million ( ( 30.0 ) % ) Net income per share Diluted net income per share Three months ended ( Yen ) ( Yen ) June 30 , 2026 22.74 21.54 June 30 , 2025 Note : Diluted net income per share in the three months ended June 2026 is not stated because there are no outstanding potential shares . ( 2 ) Consolidated financial condition As of June 30 , 2026 March 31 , 2026 Total assets Net assets Equity capital ratio ( Million yen ) 371,786 385,109 ( Million yen ) % 39.5 39.2 148,154 152,428 Reference : Equity : As of June 30 , 2026 : ¥ 146,828 million ; FY ended March 2026 : ¥ 151,070 million 2. Dividends Annual dividends First quarter - end Second quarter - end ( Yen ) FY ended March 2026 ( Yen ) 0.00 Third quarter - end ( Yen ) Fiscal year - end Total ( Yen ) 60.00 ( Yen ) 60.00 FY ending March 2027 FY ending March 2027 0.00 65.00 65.00 ( forecast ) Note : Revisions made in most recently announced dividend forecasts : None 3. Forecast of consolidated financial results for the fiscal year ending March 31 , 2027 ( April 1 , 2026 - March 31 , 2027 ) ( Percentages represent changes from the corresponding period of the previous year for cumulative quarterly figures . ) Net sales Operating profit Cumulative through ( Million yen ) 345,000 second quarter Full - year 740,000 % 3.5 3.0 ( Million yen ) 8,500 % 3.3 Ordinary profit ( Million yen ) 8,500 % ( 3.1 ) 26,000 6.2 26,500 0.6 Profit attributable to owners of parent ( Million yen ) 5,500 0.5 16,000 19.5 Net income per share % ( Yen ) 60.03 174.99 Note : Revisions made in most recently announced forecasts of business performance : None
Page 2
Notes (1) Significant changes in the scope of consolidation during the consolidated cumulative quarter: Yes New inclusion: 1 company (Notes) , Elimination: 1 company (Notes) (Notes) Details are in the attached document Page 10 “Changes in the scope of consolidation or of application of equity method” (2) Application of special accounting methods for preparation of quarterly consolidated financial statements None (3) Changes made in accounting policies, accounting estimates, and/or restatements: (i) Changes in accounting policies associated with changes in accounting standards, etc. : None (ii) Any changes in accounting policies other than those under (i) above: None (iii) Changes in accounting estimates: None (iv) Restatements: None (4) Number of shares issued and outstanding (common stocks) (i) Number of shares issued and outstanding at the end of the period (including treasury share) (ii) Number of treasury share at the end of the period (iii) Average number of shares during the period (quarterly cumulative) * Review of the attached quarterly consolidated financial statements by a Certified Public Accountant or an audit firm : None * Information on appropriate use of financial forecasts and other special notes: • The forecasts of financial results and other forward-looking statements provided herein are based on information available at the time this document was prepared, and certain assumptions considered reasonable. The Company does not guarantee that these forecasts will be achieved. Actual results may differ significantly from forecasts due to various factors. For assumptions underlying forecasts of financial results, notes on use of forecasts of financial results, and other related information, please refer to “Information on consolidated financial forecasts and other forward-looking statements” on page 3 of the Annexed Materials. As of June 30, 2026 94,350,134 shares As of March 31, 2026 94,350,134 shares As of June 30, 2026 2,699,500 shares As of March 31, 2026 2,331,200 shares As of June 30, 2026 91,926,859 shares As of June 30, 2025 94,285,134 shares
Page 3
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 1 Index of attached materials 1. Overview of operating results, etc. ........................................................................................................ 2 (1) Overview of business results of consolidated cumulative quarter ......................................................... 2 (2) Overview of financial position for the consolidated cumulative quarter ............................................... 3 (3) Information on consolidated financial forecasts and other forward-looking statements ........................ 3 2. Quarterly consolidated financial statements and notes thereto .............................................................. 4 (1) Quarterly consolidated balance sheet ..................................................................................................... 4 (2) Quarterly consolidated statement of income and consolidated statement of comprehensive income .... 6 (3) Notes on quarterly consolidated financial statements ............................................................................ 8 (Notes on segment information, etc.) ..................................................................................................... 8 (Notes in the event of significant changes in the amount of shareholders' equity) ................................ 10 (Notes on the going concern assumption) ............................................................................................ 10 (Notes on statements of Cash Flows) ................................................................................................... 10 (Changes in the scope of consolidation or of application of equity method) ....................................... 10
Page 4
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 2 1. Overview of business results (1) Overview of business results of consolidated cumulative quarter The Japanese economy during the first quarter of the current consolidated cumulative period, showed signs of a moderate recovery, supported by improvements in employment and income environments and effects of various policies. However, the economic outlook remains uncertain due to concerns about geopolitical risks surrounding the situation in the Middle East, price trends in energy and raw materials and fluctuations in financial and capital markets. Japanese healthcare industry in which the Group operates, the operating environment for medical institutions remained challenging due to rising prices and labor costs, prices of pharmaceuticals and medical supplies, logistics costs and labor shortages. Meanwhile, the FY2026 medical fee revision included substantial revisions for acute-care hospitals, and with discussions intensifying on measures such as compensation for consumption tax on medical equipment purchases and subsidies for the reconstruction of aging hospitals, signs of a recovery in capital investment have begun to emerge. Furthermore, under the New Regional Healthcare Plan toward 2040, medical institutions are required to reorganize and consolidate healthcare functions in accordance with the circumstances of each region and to establish sustainable and efficient healthcare delivery systems. Under such conditions, the Group’s net sales remained firm, and, as a result of implementing measures to improve profitability in each business, results were generally in line with the plan. Furthermore, as the second year of the Group’s Medium-term management plan “SHIP VISION 2030”, the Group has steadily engaged in promoting three key measures “Creating new business”, “Reorganization and integration” and “Expansion of the field of growth” under the basic policy “Portfolio Management through the Optimization of Group Management Resources”. For the first quarter of the current consolidated cumulative period, the various factors noted above resulted in net sales of 176,361 million yen (up 8.0% YoY), operating profit of 2,784 million yen (down 5.7% YoY), ordinary profit of 3,383 million yen (up 9.2% YoY), and profit attributable to owners of the parent of 2,090 million yen (up 2.9% YoY). Business results by segment are summarized below. (i) Total Pack Produce business In Total Pack Produce business, revenue and profit increased YoY due to the steady progress in projects whereas the number of completed projects in manufacturing-related business decreased YoY. As a result, this segment recorded net sales of 26,659 million yen (up 11.9% YoY) and segment profit (operating profit) of 467 million yen (up 0.4% YoY). (ii) Medical Supply business In Medical Supply business, revenue increased due to the steady progress in operation of newly contracted SPD facilities and expansion of contracted services of existing SPD facilities. On the other hand, profit decreased due to lower equipment replacement demand than in the corresponding period of the previous year and delay in price negotiations with manufacturers in some cases until the second quarter or later. As a result, this segment recorded net sales of 131,991 million yen (up 8.3% YoY) and segment profit (operating profit) of 1,088 million yen (down 7.7% YoY). (iii) Lifecare business In nursing care service, operating costs increased due to rising prices and higher expenses required to maintain service quality. In the food provision service, revenue decreased YoY due to contract termination of unprofitable facilities. On the other hand, profit increased, partly because the introduction of fully cooked foods progressed steadily. As a result, this segment recorded net sales of 9,103 million yen (down 1.4% YoY) and segment profit (operating profit) of 463 million yen (up 11.4% YoY). (iv) Dispensing Pharmacy business In Dispensing Pharmacy business, revenue increased due to the small-scale M&A and contribution of new stores. On the other hand, profit declined due to the impact of the June revision of dispensing fees and a decrease in the number of prescriptions at existing stores, as the prevalence of infectious diseases, including COVID-19 and influenza, remained lower than in typical years. As a result, this segment recorded net sales of 8,607 million yen (up 3.1% YoY) and segment profit (operating profit) of 850 million yen (down 8.3% YoY).
Page 5
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 3 (2) Overview of financial position of the consolidated cumulative quarter Assets at the end of the consolidated first quarter stood at 371,786 million yen, down 13,322 million yen from the end of the previous consolidated fiscal year. The primary reasons for this decline included decreases of 20,776 million yen in “notes and accounts receivable - trade, and contract assets ” and 2,813 million yen in “cash and deposits”, despite increases of 4,996 million yen in “securities”, 2,438 million yen in “merchandise and finished goods” and 1,625 million yen in “electronically recorded monetary claims – operating”. Liabilities stood at 223,632 million yen, down 9,049 million yen from the end of the previous consolidated fiscal year. The primary reasons for this decline included decreases of 6,126 million yen in “notes and accounts payable – trade” and 4,731 million yen in “income taxes payable”, despite increase of 913 million yen in “electronically recorded obligations – operating”. Net assets stood at 148,154 million yen, down 4,273 million yen from the end of the previous consolidated fiscal year. The primary reasons for this decrease included decrease of 5,521 million yen in “retained earnings” due to payment of dividends, despite increase of 2,090 million yen in “retained earnings” from profit attributable to owners of parent. As a result of all these factors, equity capital ratio at the end of the consolidated first quarter stood at 39.5% (up 0.3 percentage points from the end of the previous consolidated fiscal year). (3) Information on consolidated financial forecasts and other forward-looking statements Results were generally in line with the initial plan, and there has been no change to the consolidated financial forecast announced on May 12, 2026.
Page 6
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 4 2. Quarterly consolidated financial statements and notes thereto (1) Quarterly consolidated balance sheet (Unit: Million yen) As of March 31, 2026 As of June 30, 2026 Assets Current assets Cash and deposits 80,566 77,752 Notes, accounts receivable, and contract assets 140,000 119,223 Electronically recorded monetary claims – operating 8,521 10,147 Securities - 4,996 Merchandise and finished goods 24,544 26,982 Work in process 4,336 4,825 Raw materials and supplies 1,577 1,866 Other 11,076 11,904 Allowance for doubtful accounts (23) (26) Total current assets 270,599 257,672 Non-current assets Property, plant, and equipment Buildings and structures, net 20,841 20,729 Land 17,951 17,894 Real estate for rent, net 6,509 6,395 Other, net 11,361 11,321 Total property, plant, and equipment 56,663 56,340 Intangible assets Goodwill 6,706 6,556 Other 5,013 4,889 Total intangible assets 11,720 11,445 Investments and other assets Investment securities 27,690 27,936 Long-term loans receivable 10,754 10,763 Other 13,488 13,508 Allowance for doubtful accounts (5,808) (5,881) Total investments and other assets 46,125 46,327 Total non-current assets 114,510 114,113 Total assets 385,109 371,786
Page 7
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 5 (Unit: Million yen) As of March 31, 2026 As of June 30, 2026 Liabilities Current liabilities Notes and accounts payable - trade 127,939 121,813 Electronically recorded obligations - operating 36,700 37,614 Short-term loans payable 1,333 1,368 Income taxes payable 6,046 1,314 Provision for bonuses 3,324 3,392 Other 20,569 21,681 Total current liabilities 195,914 187,185 Non-current liabilities Long-term loans payable 25,606 25,172 Net defined benefit liability 3,427 3,405 Asset retirement obligations 1,208 1,213 Other 6,524 6,655 Total non-current liabilities 36,767 36,446 Total liabilities 232,681 223,632 Net assets Shareholders' equity Capital stock 15,553 15,553 Capital surplus 19,417 19,417 Retained earnings 116,758 113,327 Treasury share (5,049) (5,823) Total shareholders' equity 146,679 142,474 Accumulated other comprehensive income Valuation differences on available-for-sale securities 4,468 4,409 Deferred gains or losses on hedges 2 2 Foreign currency translation adjustments (185) (182) Remeasurements of defined benefit plans 105 124 Total accumulated other comprehensive income 4,391 4,353 Non-controlling interests 1,357 1,326 Total net assets 152,428 148,154 Total liabilities and net assets 385,109 371,786
Page 8
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 6 (2) Quarterly consolidated statement of income and consolidated statement of comprehensive income Quarterly consolidated statement of income Consolidated cumulative first quarter (Unit: Million yen) Three months ended June 30, 2025 Three months ended June 30, 2026 Net sales 163,310 176,361 Cost of sales 149,577 162,718 Gross profit 13,733 13,643 Sales, general, and administrative expenses 10,779 10,859 Operating profit 2,953 2,784 Non-operating profit Interest income 55 71 Dividend income 135 139 Equity in earnings of affiliates 144 299 Foreign exchange gain - 70 Other 173 148 Total non-operating profit 508 730 Non-operating expenses Interest expenses 112 100 Foreign exchange loss 219 - Provision for doubtful accounts - 15 Other 30 15 Total non-operating expenses 362 130 Ordinary profit 3,099 3,383 Extraordinary profit Gains on sales of non-current assets 8 1 Gain on extinguishment of tie-in shares 3 - Other 0 - Total extraordinary profit 12 1 Extraordinary losses Losses on retirement of non-current assets 18 27 Other 0 0 Total extraordinary losses 18 27 Profit before income taxes 3,094 3,357 Income taxes - current 1,073 1,114 Income taxes - deferred 44 187 Total income taxes 1,117 1,301 Profit 1,976 2,055 Loss attributable to non-controlling interests (54) (34) Profit attributable to owners of parent 2,030 2,090
Page 9
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 7 Quarterly consolidated statement of comprehensive income Consolidated cumulative first quarter (Unit: Million yen) Three months ended June 30, 2025 Three months ended June 30, 2026 Net income 1,976 2,055 Other comprehensive income Valuation differences on available-for-sale securities 507 (56) Foreign currency translation adjustments (91) 22 Remeasurements of defined benefit plans (6) 17 Share of other comprehensive income of entities accounted for using equity method (17) (11) Total other comprehensive income 391 (28) Comprehensive income 2,367 2,026 (Breakdown) Comprehensive income attributable to owners of parent 2,461 2,052 Comprehensive income attributable to non-controlling interests (94) (25)
Page 10
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 8 (3) Notes on consolidated quarterly financial statements (Notes on Segment information, etc.) I. Previous consolidated cumulative first quarter (April 1,2025 – June 30, 2025) 1 Net sales and profit (loss) by reportable segments (Unit: Million yen) Reportable segment Adjustments*1 Amount recorded on consolidated financial statements*2 Total Pack Produce business Medical Supply business Lifecare business Dispensing Pharmacy business Subtotal Net sales (1) Sales to outside customers 23,834 121,896 9,234 8,346 163,310 － 163,310 (2) Intersegment sales or transfers 436 409 26 31 904 (904) － Subtotal 24,271 122,306 9,260 8,377 164,215 (904) 163,310 Segment profit 466 1,178 415 928 2,989 (35) 2,953 Notes: 1. The figure of (35) million yen in adjustments to segment profit includes (14) million yen for the cancellation of intersegment transactions and (26) million yen for companywide costs not allocated to an individual reportable segment. Companywide costs mainly comprise the net amount of parent-company income from subsidiaries for operating expenses, operating expenses, and sales, general and administrative expenses not attributable to individual reportable segments. 2. Segment profit is adjusted against the operating profit reported on the Quarterly consolidated statement of income. 2 Information on impairment loss and goodwill on fixed assets by reportable segments During the cumulative consolidated first quarter, there were no material impairment losses on non-current assets, no material changes in the amount of goodwill, and no material gains on bargain purchases.
Page 11
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 9 Ⅱ Consolidated cumulative first quarter (April 1,2026 – June 30, 2026) 1 Net sales and profit (loss) by reportable segments (Unit: Million yen) Reportable segment Adjustments*1 Amount recorded on consolidated financial statements*2 Total Pack Produce business Medical Supply business Lifecare business Dispensing Pharmacy business Subtotal Net sales (1) Sales to outside customers 26,659 131,991 9,103 8,607 176,361 － 176,361 (2) Intersegment sales or transfers 592 204 27 37 863 (863) － Subtotal 27,252 132,196 9,130 8,644 177,224 (863) 176,361 Segment profit 467 1,088 463 850 2,870 (86) 2,784 Notes: 1. The figure of (86) million yen in adjustments to segment profit includes (31) million yen for the cancellation of intersegment transactions and (54) million yen for companywide costs not allocated to an individual reportable segment. Companywide costs mainly comprise the net amount of parent-company income from subsidiaries for operating expenses, operating expenses, and sales, general and administrative expenses not attributable to individual reportable segments. 2.Segment profit is adjusted against the operating profit reported on the Quarterly consolidated statement of income. 2 Information on impairment loss and goodwill on fixed assets by reportable segments During the cumulative consolidated first quarter, there were no material impairment losses on non-current assets, no material changes in the amount of goodwill, and no material gains on bargain purchases.
Page 12
SHIP HEALTHCARE HOLDINGS, INC. (3360): Consolidated Financial Results for the Three Months Ended June 30, 2026 10 (Notes in the event of significant changes in the amount of shareholders' equity) (Acquisition of treasury shares) The Company acquired 368,300 treasury shares based on the resolution of its board of directors held on June 5, 2026. Accordingly, treasury share increased by 774 million yen. (Notes on the going concern assumption) None (Notes on statements of Cash Flows) The quarterly consolidated statement of cash flows for the first quarter of the consolidated cumulative period has not been prepared. However, depreciation and amortization of the period (including amortization of intangible assets other than goodwill ) and amortization of goodwill are below: Previous consolidated cumulative first quarter (April 1, 2025 – June 30, 2025) Consolidated cumulative first quarter (April 1, 2026 – June 30, 2026) Depreciation and amortization 1,311 million yen 1,375 million yen Amortization of goodwill 406 million yen 388 million yen (Changes in the scope of consolidation or of application of equity method) (Changes in the scope of consolidation) During the first quarter of this consolidated fiscal year, MYNS CO., LTD. was newly included in the scope of consolidation by acquisition of its shares. SHIP HEALTHCARE PHARMACY CO., LTD., which is a consolidated subsidiary, conducted an absorption-type merger with DELPHIA CO., LTD., which was a consolidated subsidiary.